Search Results

Filter
  • 1-10 of  277 results for ""Drug Eruptions""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patients.

  • Authors : Tomsitz D; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany. Electronic address: .; Kerl K

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/pathology ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Dec; Vol. 91 (6), pp. 1136-1142. Date of Electronic Publication: 2024 Aug 29.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.

  • Authors : Wongvibulsin S; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/drug therapy ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/epidemiology ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Mar; Vol. 86 (3), pp. 563-572. Date of Electronic Publication: 2021 Apr 02.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Report

Granulomatous/sarcoid-like reactions in the setting of programmed cell death-1 inhibition: a potential mimic of disease recurrence.

  • Authors : Hiraki T; Department of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences, Sakuragaoka, Kagoshima, Japan.; Department of Surgical Pathology, Kagoshima University Hospital, Sakuragaoka, Kagoshima, Japan.

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/diagnosis ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/metabolism ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/pathology

  • Source: Journal of cutaneous pathology [J Cutan Pathol] 2020 Feb; Vol. 47 (2), pp. 154-160. Date of Electronic Publication: 2019 Sep 01.Publisher: Wiley Country of Publication: United States NLM ID: 0425124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0560

Record details

×
Report

Interstitial granulomatous dermatitis and granulomatous arteritis in the setting of PD-1 inhibitor therapy for metastatic melanoma.

  • Authors : Singh P; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.; Wolfe SP

Subjects: Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/metabolism ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/pathology ; Melanoma*/Melanoma*/Melanoma*/drug therapy

  • Source: Journal of cutaneous pathology [J Cutan Pathol] 2020 Jan; Vol. 47 (1), pp. 65-69. Date of Electronic Publication: 2019 Aug 25.Publisher: Wiley Country of Publication: United States NLM ID: 0425124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0560

Record details

×
Academic Journal

Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A review.

  • Authors : Ravi V; Department of Dermatology, Keck School of Medicine at the University of Southern California, Los Angeles, California.; Maloney NJ

Subjects: Checkpoint Kinase 1/Checkpoint Kinase 1/Checkpoint Kinase 1/*antagonists & inhibitors ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Melanoma/Melanoma/Melanoma/*drug therapy

  • Source: Dermatologic therapy [Dermatol Ther] 2019 Sep; Vol. 32 (5), pp. e13074. Date of Electronic Publication: 2019 Sep 04.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Delayed skin toxicity associated with pembrolizumab therapy for metastatic melanoma.

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*adverse effects ; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology

  • Source: European journal of dermatology : EJD [Eur J Dermatol] 2019 Jun 01; Vol. 29 (3), pp. 349-351.Publisher: John Libbey Eurotext Country of Publication: France NLM ID: 9206420 Publication Model: Print Cited Medium: Internet ISSN: 1952-4013

Record details

×
Academic Journal

BRAF Inhibitor-Associated Granulomatous Dermatitis: A Report of 3 Cases.

  • Authors : Hui Ong EL; Dermatology Department, Chelsea Westminster Hospital, London, United Kingdom.; Sinha R

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Granuloma/Granuloma/Granuloma/*chemically induced

  • Source: The American Journal of dermatopathology [Am J Dermatopathol] 2019 Mar; Vol. 41 (3), pp. 214-217.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7911005 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Case of Perforating Folliculitis Induced by Vemurafenib.

  • Authors : Shiraishi K; Department of Dermatology , Ehime University Graduate School of Medicine, 791-0295 Toon, Japan. .; Masunaga T

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Folliculitis/Folliculitis/Folliculitis/*chemically induced

  • Source: Acta dermato-venereologica [Acta Derm Venereol] 2019 Feb 01; Vol. 99 (2), pp. 230-231.Publisher: Society for the Publication of Acta Dermato-Venereologica Country of Publication: Sweden NLM ID: 0370310 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab: First Case Reported With Isolated Cutaneous Findings.

  • Authors : Cervantes J; Departamento de Dermatología y Cirugía Cutánea, Facultad de Medicina, Universidad Miller de Miami, Miami, Florida, Estados Unidos. Electronic address: .; Rosen A

Subjects: Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*adverse effects ; Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Granuloma/Granuloma/Granuloma/*chemically induced

  • Source: Actas dermo-sifiliograficas [Actas Dermosifiliogr (Engl Ed)] 2019 Jan - Feb; Vol. 110 (1), pp. 43-49. Date of Electronic Publication: 2018 Oct 30.Publisher: Elsevier España Country of Publication: Spain NLM ID: 101777537 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  277 results for ""Drug Eruptions""